Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Henry Szechtman

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Activities & Behaviors

Living Beings

Anatomy

Brain

Disorders

Procedures

Emission-Computed Tomography

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
23
Sakic, Boris
21
Denburg, Judah
15
Eilam, David
13
Nahmias, Claude
12
Culver, Kirsten
7
Denburg, Susan
6
Sullivan, Ron
5
Woody, Erik
5
Carbotte, RM
4
Ballok, David
3
Hall, Geoffrey
3
Szumlinski, Karen
3
Perreault, Melissa
3
Golani, Ilan
2
Rosenfeld, JM

Sign-in to see all Coauthors

Publications

TOP 3
Zor R; Keren H; Hermesh H; Szechtman H; Mort J; Eilam D
Obsessive-compulsive disorder: a disorder of pessimal (non-functional) motor behavior.
Beerepoot Pieter; Lam Vincent; Luu Alice; Tsoi Bernice; Siebert Daniel; Szechtman Henry
Effects of salvinorin A on locomotor sensitization to D2/D3 dopamine agonist quinpirole.
Culver Kirsten E; Szechtman Henry; Levant Beth
Altered dopamine D2-like receptor binding in rats with behavioral sensitization to quinpirole: effects of pre-treatment with Ro 41-1049.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Henry Szechtman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Zor R; Keren H; Hermesh H; Szechtman H; Mort J; Eilam D
Obsessive-compulsive disorder: a disorder of pessimal (non-functional) motor behavior.
Acta psychiatrica Scandinavica 2009;120(4):288-98.
2008: Beerepoot Pieter; Lam Vincent; Luu Alice; Tsoi Bernice; Siebert Daniel; Szechtman Henry
Effects of salvinorin A on locomotor sensitization to D2/D3 dopamine agonist quinpirole.
Neuroscience letters 2008;446(2-3):101-4.
2008: Culver Kirsten E; Szechtman Henry; Levant Beth
Altered dopamine D2-like receptor binding in rats with behavioral sensitization to quinpirole: effects of pre-treatment with Ro 41-1049.
European journal of pharmacology 2008;592(1-3):67-72.
2008: Dvorkin Anna; Culver Kirsten E; Waxman Donna; Szechtman Henry; Kolb Bryan
Effects of hypophysectomy on compulsive checking and cortical dendrites in an animal model of obsessive-compulsive disorder.
Behavioural pharmacology 2008;19(4):271-83.
2007: Perreault Melissa L; Graham Dawn; Scattolon Sarah; Wang Yufang; Szechtman Henry; Foster Jane A
Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats.
Psychopharmacology 2007;194(4):485-96.
2007: Perreault Melissa L; Seeman Philip; Szechtman Henry
Kappa-opioid receptor stimulation quickens pathogenesis of compulsive checking in the quinpirole sensitization model of obsessive-compulsive disorder (OCD).
Behavioral neuroscience 2007;121(5):976-91.
2006: Szechtman H; Woody E Z
Obsessive-compulsive disorder as a disturbance of security motivation: constraints on comorbidity.
Neurotoxicity research 2006;10(2):103-12.
2006: Seeman Philip; Schwarz Johannes; Chen Jiang-Fan; Szechtman Henry; Perreault Melissa; McKnight G Stanley; Roder John C; Quirion Rémi; Boksa Patricia; Srivastava Lalit K; Yanai Kazuhiko; Weinshenker David; Sumiyoshi Tomiki
Psychosis pathways converge via D2high dopamine receptors.
Synapse (New York, N.Y.) 2006;60(4):319-46.
2006: Perreault Melissa L; Graham Dawn; Bisnaire Liane; Simms Jennifer; Hayton Scott; Szechtman Henry
Kappa-opioid agonist U69593 potentiates locomotor sensitization to the D2/D3 agonist quinpirole: pre- and postsynaptic mechanisms.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(9):1967-81.
2006: Dvorkin Anna; Culver Kirsten E; Szechtman Henry
Differential effects of clorgyline on sensitization to quinpirole in rats tested in small and large environments.
Psychopharmacology 2006;186(4):534-43.
2006: Varghese Ashwin K; Verdú Elena F; Bercik Premysl; Khan Waliul I; Blennerhassett Patricia A; Szechtman Henry; Collins Stephen M
Antidepressants attenuate increased susceptibility to colitis in a murine model of depression.
Gastroenterology 2006;130(6):1743-53.
2006: Dvorkin Anna; Perreault Melissa L; Szechtman Henry
Development and temporal organization of compulsive checking induced by repeated injections of the dopamine agonist quinpirole in an animal model of obsessive-compulsive disorder.
Behavioural brain research 2006;169(2):303-11.
2006: Anderson Kelly K; Ballok David A; Prasad Neena; Szechtman Henry; Sakic Boris
Impaired response to amphetamine and neuronal degeneration in the nucleus accumbens of autoimmune MRL-lpr mice.
Behavioural brain research 2006;166(1):32-8.
2006: Eilam David; Zor Rama; Szechtman Henry; Hermesh Haggai
Rituals, stereotypy and compulsive behavior in animals and humans.
Neuroscience and biobehavioral reviews 2006;30(4):456-71.
2005: Sakic Boris; Kirkham David L; Ballok David A; Mwanjewe James; Fearon Ian M; Macri Joseph; Yu Guanhua; Sidor Michelle M; Denburg Judah A; Szechtman Henry; Lau Jonathan; Ball Alexander K; Doering Laurie C
Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease.
Journal of neuroimmunology 2005;169(1-2):68-85.
2005: Woody Erik Z; Lewis Victoria; Snider Lisa; Grant Hilary; Kamath Markad; Szechtman Henry
Induction of compulsive-like washing by blocking the feeling of knowing: an experimental test of the security-motivation hypothesis of obsessive-compulsive disorder.
Behavioral and brain functions : BBF 2005;1():11.
2005: Eilam David; Szechtman Henry
Psychostimulant-induced behavior as an animal model of obsessive-compulsive disorder: an ethological approach to the form of compulsive rituals.
CNS spectrums 2005;10(3):191-202.
2004: Van Ameringen Michael; Mancini Catherine; Szechtman Henry; Nahmias Claude; Oakman Jonathan M; Hall Geoffrey B C; Pipe Beth; Farvolden Peter
A PET provocation study of generalized social phobia.
Psychiatry research 2004;132(1):13-8.
2004: Lomanowska Anna; Gormley Stephanie; Szechtman Henry
Presynaptic stimulation and development of locomotor sensitization to the dopamine agonist quinpirole.
Pharmacology, biochemistry, and behavior 2004;77(3):617-22.
2004: Hall Geoffrey B C; Witelson Sandra F; Szechtman Henry; Nahmias Claude
Sex differences in functional activation patterns revealed by increased emotion processing demands.
Neuroreport 2004;15(2):219-23.
2004: Szechtman Henry; Woody Erik
Obsessive-compulsive disorder as a disturbance of security motivation.
Psychological review 2004;111(1):111-27.
2004: Culver Kirsten E; Szechtman Henry
Hypophysectomy does not block sensitization to the dopamine agonist quinpirole or its modulation by the MAOI clorgyline.
Hormones and behavior 2004;45(1):23-30.
2003: Gabriele Joseph; Culver Kirsten; Sharma Sunjay; Zhang Bingjun; Szechtman Henry; Mishra Ram
Asymmetric modulation of a catecholamine-regulated protein in the rat brain, following quinpirole administration.
Synapse (New York, N.Y.) 2003;49(4):261-9.
2003: Hall Geoffrey B C; Szechtman Henry; Nahmias Claude
Enhanced salience and emotion recognition in Autism: a PET study.
The American journal of psychiatry 2003;160(8):1439-41.
2003: Woody Erik Z; Szechtman Henry
How can brain activity and hypnosis inform each other?
The International journal of clinical and experimental hypnosis 2003;51(3):232-55.
2003: Culver Kirsten E; Szechtman Henry
Clorgyline-induced switch from locomotion to mouthing in sensitization to the dopamine D2/D3 agonist quinpirole in rats: role of sigma and imidazoline I2 receptors.
Psychopharmacology 2003;167(2):211-8.
2003: Ballok David A; Szechtman Henry; Sakic Boris
Taste responsiveness and diet preference in autoimmune MRL mice.
Behavioural brain research 2003;140(1-2):119-30.
2002: Culver K E; Rosenfeld J M; Szechtman H
Monoamine oxidase inhibitor-induced blockade of locomotor sensitization to quinpirole: role of striatal dopamine uptake inhibition.
Neuropharmacology 2002;43(3):385-93.
2002: Sakic Boris; Lacosta Susan; Denburg Judah A; Szechtman Henry
Altered neurotransmission in brains of autoimmune mice: pharmacological and neurochemical evidence.
Journal of neuroimmunology 2002;129(1-2):84-96.
2002: Szumlinski Karen K; Szechtman Henry
D2 receptor blockade in the dorsal raphe increases quinpirole-induced locomotor excitation.
Neuroreport 2002;13(5):563-6.
2002: Shaldubina A; Einat H; Szechtman H; Shimon H; Belmaker R H
Preliminary evaluation of oral anticonvulsant treatment in the quinpirole model of bipolar disorder.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(3):433-40.
2002: Tizabi Yousef; Louis Vely A; Taylor Charles T; Waxman Donna; Culver Kirsten E; Szechtman Henry
Effect of nicotine on quinpirole-induced checking behavior in rats: implications for obsessive-compulsive disorder.
Biological psychiatry 2002;51(2):164-71.
2001: Ben-Pazi A; Szechtman H; Eilam D
The morphogenesis of motor rituals in rats treated chronically with the dopamine agonist quinpirole.
Behavioral neuroscience 2001;115(6):1301-17.
2001: Maric D; Millward J M; Ballok D A; Szechtman H; Denburg J A; Barker J L; Sakic B
Neurotoxic properties of cerebrospinal fluid from behaviorally impaired autoimmune mice.
Brain research 2001;920(1-2):183-93.
2001: Sakic B; Gauldie J; Denburg J A; Szechtman H
Behavioral effects of infection with IL-6 adenovector.
Brain, behavior, and immunity 2001;15(1):25-42.
2001: Szechtman H; Eckert M J; Tse W S; Boersma J T; Bonura C A; McClelland J Z; Culver K E; Eilam D
Compulsive checking behavior of quinpirole-sensitized rats as an animal model of Obsessive-Compulsive Disorder(OCD): form and control.
BMC neuroscience 2001;2():4.
2000: Sakic B; Kolb B; Whishaw I Q; Gorny G; Szechtman H; Denburg J A
Immunosuppression prevents neuronal atrophy in lupus-prone mice: evidence for brain damage induced by autoimmune disease?
Journal of neuroimmunology 2000;111(1-2):93-101.
2000: Szumlinski K K; Goodwill A M; Szechtman H
Locomotor sensitization to quinpirole in rats: effects of drug abstinence and sex.
Psychopharmacology 2000;152(3):304-11.
2000: Culver K E; Rosenfeld J M; Szechtman H
A switch mechanism between locomotion and mouthing implicated in sensitization to quinpirole in rats.
Psychopharmacology 2000;151(2-3):202-10.
2000: Sakic B; Maric I; Koeberle P D; Millward J M; Szechtman H; Maric D; Denburg J A
Increased TUNEL staining in brains of autoimmune Fas-deficient mice.
Journal of neuroimmunology 2000;104(2):147-54.
1999: Sakic B; Laflamme N; Crnic L S; Szechtman H; Denburg J A; Rivest S
Reduced corticotropin-releasing factor and enhanced vasopressin gene expression in brains of mice with autoimmunity-induced behavioral dysfunction.
Journal of neuroimmunology 1999;96(1):80-91.
1999: Szechtman H; Culver K; Eilam D
Role of dopamine systems in obsessive-compulsive disorder (OCD): implications from a novel psychostimulant-induced animal model.
Polish journal of pharmacology 1999;51(1):55-61.
1998: Szechtman H; Sulis W; Eilam D
Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD).
Behavioral neuroscience 1998;112(6):1475-85.
1998: Sakic B; Szechtman H; Denburg J A; Gorny G; Kolb B; Whishaw I Q
Progressive atrophy of pyramidal neuron dendrites in autoimmune MRL-lpr mice.
Journal of neuroimmunology 1998;87(1-2):162-70.
1998: Sullivan R M; Talangbayan H; Einat H; Szechtman H
Effects of quinpirole on central dopamine systems in sensitized and non-sensitized rats.
Neuroscience 1998;83(3):781-9.
1998: Szechtman H; Woody E; Bowers K S; Nahmias C
Where the imaginal appears real: a positron emission tomography study of auditory hallucinations.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(4):1956-60.
1997: Culver K E; Szechtman H
Monoamine oxidase inhibitor sensitive site implicated in sensitization to quinpirole.
European journal of pharmacology 1997;339(2-3):109-11.
1997: Szumlinski K K; Allan M; Talangbayan H; Tracey A; Szechtman H
Locomotor sensitization to quinpirole: environment-modulated increase in efficacy and context-dependent increase in potency.
Psychopharmacology 1997;134(2):193-200.
1997: Sakic B; Szechtman H; Denburg J A
Neurobehavioral alterations in autoimmune mice.
Neuroscience and biobehavioral reviews 1997;21(3):327-40.
1997: MacFarlane J G; List S J; Moldofsky H; Firnau G; Chen J J; Szechtman H; Garnett S; Nahmias C
Dopamine D2 receptors quantified in vivo in human narcolepsy.
Biological psychiatry 1997;41(3):305-10.
1997: Sakic B; Szechtman H; Braciak T; Richards C; Gauldie J; Denburg J A
Reduced preference for sucrose in autoimmune mice: a possible role of interleukin-6.
Brain research bulletin 1997;44(2):155-65.
1997: Farrell M; Sakic B; Szechtman H; Denburg J A
Effect of cyclophosphamide on leukocytic infiltration in the brain of MRL/lpr mice.
Lupus 1997;6(3):268-74.
1997: Szechtman H; Sakic B; Denburg J A
Behaviour of MRL mice: an animal model of disturbed behaviour in systemic autoimmune disease.
Lupus 1997;6(3):223-9.
1996: Einat H; Einat D; Allan M; Talangbayan H; Tsafnat T; Szechtman H
Associational and nonassociational mechanisms in locomotor sensitization to the dopamine agonist quinpirole.
Psychopharmacology 1996;127(2):95-101.
1996: Sakic B; Szechtman H; Stead R H; Denburg J A
Joint pathology and behavioral performance in autoimmune MRL-lpr Mice.
Physiology & behavior 1996;60(3):901-5.
1996: Sakic B; Denburg J A; Denburg S D; Szechtman H
Blunted sensitivity to sucrose in autoimmune MRL-lpr mice: a curve-shift study.
Brain research bulletin 1996;41(5):305-11.
1995: Sakic B; Szechtman H; Denburg S D; Denburg J A
Immunosuppressive treatment prevents behavioral deficit in autoimmune MRL-lpr mice.
Physiology & behavior 1995;58(4):797-802.
1995: Sullivan R M; Szechtman H
Asymmetrical influence of mesocortical dopamine depletion on stress ulcer development and subcortical dopamine systems in rats: implications for psychopathology.
Neuroscience 1995;65(3):757-66.
1995: Einat H; Szechtman H
Perseveration without hyperlocomotion in a spontaneous alternation task in rats sensitized to the dopamine agonist quinpirole.
Physiology & behavior 1995;57(1):55-9.
1995: Denburg J A; Denburg S D; Carbotte R M; Sakic B; Szechtman H
Nervous system lupus: pathogenesis and rationale for therapy.
Scandinavian journal of rheumatology 1995;24(5):263-73.
1994: Sakic B; Szechtman H; Talangbayan H; Denburg S D; Carbotte R M; Denburg J A
Disturbed emotionality in autoimmune MRL-lpr mice.
Physiology & behavior 1994;56(3):609-17.
1994: Szechtman H; Dai H; Mustafa S; Einat H; Sullivan R M
Effects of dose and interdose interval on locomotor sensitization to the dopamine agonist quinpirole.
Pharmacology, biochemistry, and behavior 1994;48(4):921-8.
1994: Szechtman H; Talangbayan H; Canaran G; Dai H; Eilam D
Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy control mechanism.
Psychopharmacology 1994;115(1-2):95-104.
1994: Sullivan R M; Szechtman H
Left/right nigrostriatal asymmetry in susceptibility to neurotoxic dopamine depletion with 6-hydroxydopamine in rats.
Neuroscience letters 1994;170(1):83-6.
1994: Sakic B; Szechtman H; Talangbayan H; Denburg S; Carbotte R; Denburg J A
Behavior and immune status of MRL mice in the postweaning period.
Brain, behavior, and immunity 1994;8(1):1-13.
1994: Sullivan R M; Fraser A; Szechtman H
Asymmetrical orientation to edges of an openfield: modulation by striatal dopamine and relationship to motor asymmetries in the rat.
Brain research 1994;637(1-2):114-8.
1993: Kaplan R D; Szechtman H; Franco S; Szechtman B; Nahmias C; Garnett E S; List S; Cleghorn J M
Three clinical syndromes of schizophrenia in untreated subjects: relation to brain glucose activity measured by positron emission tomography (PET).
Schizophrenia research 1993;11(1):47-54.
1993: Sakic B; Szechtman H; Denburg S; Carbotte R; Denburg J A
Brain-reactive antibodies and behavior of autoimmune MRL-lpr mice.
Physiology & behavior 1993;54(5):1025-9.
1993: Eilam D; Szechtman H; Faigon M; Dubovik V; Feldon J; Michaelson D M
Disintegration of the spatial organization of behavior in experimental autoimmune dementia.
Neuroscience 1993;56(1):83-91.
1993: Sullivan R M; Parker B A; Szechtman H
Role of the corpus callosum in expression of behavioral asymmetries induced by a unilateral dopamine lesion of the substantia nigra in the rat.
Brain research 1993;609(1-2):347-50.
1993: Sakic B; Szechtman H; Denburg S; Carbotte R; Denburg J A
Spatial learning during the course of autoimmune disease in MRL mice.
Behavioural brain research 1993;54(1):57-66.
1993: Einat H; Szechtman H
Longlasting consequences of chronic treatment with the dopamine agonist quinpirole for the undrugged behavior of rats.
Behavioural brain research 1993;54(1):35-41.
1992: Sullivan R; Dogaru C; Szechtman H
Constriction of environmental space and the behavioral response to the dopamine agonist quinpirole.
Pharmacology, biochemistry, and behavior 1992;43(4):1217-9.
1992: Sakic B; Szechtman H; Keffer M; Talangbayan H; Stead R; Denburg J A
A behavioral profile of autoimmune lupus-prone MRL mice.
Brain, behavior, and immunity 1992;6(3):265-85.
1992: Cleghorn J M; Franco S; Szechtman B; Kaplan R D; Szechtman H; Brown G M; Nahmias C; Garnett E S
Toward a brain map of auditory hallucinations.
The American journal of psychiatry 1992;149(8):1062-9.
1992: Eilam D; Szechtman H; Spear L P
Quinpirole alters quadruped activity in rats from the second postnatal week.
Developmental psychobiology 1992;25(4):275-89.
1992: Eilam D; Talangbayan H; Canaran G; Szechtman H
Dopaminergic control of locomotion, mouthing, snout contact, and grooming: opposing roles of D1 and D2 receptors.
Psychopharmacology 1992;106(4):447-54.
1991: Eilam D; Clements K V; Szechtman H
Differential effects of D1 and D2 dopamine agonists on stereotyped locomotion in rats.
Behavioural brain research 1991;45(2):117-24.
1991: Cleghorn J M; Szechtman H; Garnett E S; Nahmias C; Brown G M; Kaplan R D; Szechtman B; Franco S
Apomorphine effects on brain metabolism in neuroleptic-naive schizophrenic patients.
Psychiatry research 1991;40(2):135-53.
1991: Cleghorn J M; Szechtman H; Garnett E S; Brown G M; Nahmias C; Szechtman B; Kaplan R; Franco S
Neuroleptic effects on regional brain metabolism in first episode schizophrenics.
Schizophrenia research 1991;5(3):208-9.
1991: Cleghorn J M; Kaplan R D; Szechtman B; Szechtman H; Brown G M; Franco S
Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function.
The Journal of clinical psychiatry 1991;52(1):26-30.
1990: Cleghorn J M; Garnett E S; Nahmias C; Brown G M; Kaplan R D; Szechtman H; Szechtman B; Franco S; Dermer S W; Cook P
Regional brain metabolism during auditory hallucinations in chronic schizophrenia.
The British journal of psychiatry : the journal of mental science 1990;157():562-70.
1990: Eilam D; Szechtman H
Dosing regimen differentiates sensitization of locomotion and mouthing to D2 agonist quinpirole.
Pharmacology, biochemistry, and behavior 1990;36(4):989-91.
1990: Ziegler M G; Szechtman H
Relation between motor asymmetry and direction of rotational behaviour under amphetamine and apomorphine in rats with unilateral degeneration of the nigrostriatal dopamine system.
Behavioural brain research 1990;39(2):123-33.
1990: Cleghorn J M; Kaplan R D; Szechtman B; Szechtman H; Brown G M
Neuroleptic drug effects on cognitive function in schizophrenia.
Schizophrenia research 1990;3(3):211-9.
1989: Cleghorn J M; Kaplan R D; Nahmias C; Garnett E S; Szechtman H; Szechtman B
Inferior parietal region implicated in neurocognitive impairment in schizophrenia.
Archives of general psychiatry 1989;46(8):758-60.
1989: Eilam D; Golani I; Szechtman H
D2-agonist quinpirole induces perseveration of routes and hyperactivity but no perseveration of movements.
Brain research 1989;490(2):255-67.
1989: Cleghorn J M; Garnett E S; Nahmias C; Firnau G; Brown G M; Kaplan R; Szechtman H; Szechtman B
Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia.
Psychiatry research 1989;28(2):119-33.
1989: Eilam D; Szechtman H
Biphasic effect of D-2 agonist quinpirole on locomotion and movements.
European journal of pharmacology 1989;161(2-3):151-7.
1988: Szechtman H
Effect of the dopamine receptor agonist apomorphine on sensory input.
Naunyn-Schmiedeberg's archives of pharmacology 1988;338(5):489-96.
1988: Brown P J; Cleghorn J M; Brown G M; Kaplan R D; Mitton J; Szechtman H; Szechtman B
Seasonal variations in prolactin levels in schizophrenia.
Psychiatry research 1988;25(2):157-62.
1988: Szechtman H; Nahmias C; Garnett E S; Firnau G; Brown G M; Kaplan R D; Cleghorn J M
Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia.
Archives of general psychiatry 1988;45(6):523-32.
1988: Brown G M; Cleghorn J M; Kaplan R D; Szechtman H; Brown P J; Szechtman B; Mitton J
Longitudinal growth hormone studies in schizophrenia.
Psychiatry research 1988;24(2):123-36.
1988: Ziegler M; Szechtman H
Differences in the behavioral profile of circling under amphetamine and apomorphine in rats with unilateral lesions of the substantia nigra.
Behavioral neuroscience 1988;102(2):276-88, 327.
1988: Szechtman H; Cleghorn J M; Brown G M; Kaplan R D; Franco S; Rosenthal K
Sensitization and tolerance to apomorphine in men: yawning, growth hormone, nausea, and hyperthermia.
Psychiatry research 1988;23(3):245-55.
1985: Szechtman H; Ornstein K; Teitelbaum P; Golani I
The morphogenesis of stereotyped behavior induced by the dopamine receptor agonist apomorphine in the laboratory rat.
Neuroscience 1985;14(3):783-98.
1982: Szechtman H; Ornstein K; Teitelbaum P; Golani I
Snout contact fixation, climbing and gnawing during apomorphine stereotypy in rats from two substrains.
European journal of pharmacology 1982;80(4):385-92.

Sign-in to see more